adamantane has been researched along with arsenic trioxide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, YF; Chern, YT; Chi, CW; Wang, JJ | 1 |
| Aller, P; Calle, C; de Blas, E; Sánchez, Y | 1 |
| Defant, A; Mancini, I; Pancher, M; Quattrone, A; Rosatti, EF; Sidarovich, V; Sighel, D; Vigna, J | 1 |
3 other study(ies) available for adamantane and arsenic trioxide
| Article | Year |
|---|---|
Effects of 1, 6-Bis[4-(4-amino-3-hydroxyphenoxy)phenyl]diamantane (DPD), a reactive oxygen species and apoptosis inducing agent, on human leukemia cells in vitro and in vivo.
Topics: Adamantane; Animals; Annexin A5; Apoptosis; Arsenic Trioxide; Arsenicals; Caspase 3; Caspases; Cell Cycle; Cell Division; HL-60 Cells; Humans; Membrane Potentials; Mice; Mice, SCID; Oxides; Reactive Oxygen Species; RNA, Messenger; Superoxide Dismutase | 2005 |
Modulation of arsenic trioxide-induced apoptosis by genistein and functionally related agents in U937 human leukaemia cells. Regulation by ROS and mitogen-activated protein kinases.
Topics: Adamantane; Antineoplastic Agents; Antioxidants; Apoptosis; Arsenic Trioxide; Arsenicals; Catechin; Cell Cycle; Drug Synergism; Enzyme Activation; Estradiol; Etoposide; Genistein; HL-60 Cells; Humans; Hydroquinones; Immunoblotting; Microscopy, Fluorescence; Mitogen-Activated Protein Kinases; Oxides; Protein Kinase Inhibitors; Reactive Oxygen Species; RNA, Small Interfering; U937 Cells | 2009 |
Expanding the Chemical Space of Arsenicin A-C Related Polyarsenicals and Evaluation of Some Analogs as Inhibitors of Glioblastoma Stem Cell Growth.
Topics: Adamantane; Arsenic Trioxide; Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Humans; Stem Cells | 2023 |